Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.

T, Sasaki; M, Sugawara; M, Fukuda

doi:10.1111/jdi.12851

Public

Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.

Shared by NobleBlocks on May 16, 2018 • 12:00 AM UTC

Authors:

Sasaki T

Sugawara M

Fukuda M

Abstract

<h4>Aims/introduction</h4>It is unclear how changes in body composition induced by sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment correlate with metabolic profile changes. We aimed to clarify how metabolic profile changes correlate with body component changes, and if SGLT2 inhibitor trea...

Subject

Skeletal muscle

Visceral Fat

Dual-energy X-ray Absorption

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!